Abstract
It is now estimated that approximately 10 % of worldwide cancers are attributable to viral infection, with the vast majority (>85 %) occurring in the developing world. Oncogenic viruses include various classes of DNA and RNA viruses and induce cancer by a variety of mechanisms. A unifying theme is that cancer develops in a minority of infected individuals and only after chronic infection of many years duration. The viruses associated with the greatest number of cancer cases are the human papillomaviruses (HPVs), which cause cervical cancer and several other epithelial malignancies, and the hepatitis viruses HBV and HCV, which are responsible for the majority of hepatocellular cancer. Other oncoviruses include Epstein–Barr virus (EBV), Kaposi’s sarcoma-associated herpes virus (KSHV), human T-cell leukemia virus (HTLV-I), and Merkel cell polyomavirus (MCPyV). Identification of the infectious cause has led to several interventions that may reduce the risk of developing these tumors. These include preventive vaccines against HBV and HPV, HPV-based testing for cervical cancer screening, anti-virals for the treatment of chronic HBV and HCV infection, and screening the blood supply for the presence of HBV and HCV. Successful efforts to identify additional oncogenic viruses in human cancer may lead to further insight into etiology and pathogenesis as well as to new approaches for therapeutic and prophylactic intervention.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Alison MR, Nicholson LJ, Lin WR (2011) Chronic inflammation and hepatocellular carcinoma. Recent Results Cancer Res 185:135–148
Arora R, Chang Y, More PS (2012) MCV and Merkel cell carcinoma: a molecular success story. Curr Opin Virol 2(4):489–498
Brotherton JM, Fridman M, May CL et al (2011) Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 377(9783):2085–2092
Butel JS, Fan H (2012) The diversity of human cancer viruses. Curr Opin Virol 2(4):449–452
Chang MH, You SL, Chen CJ et al (2009) Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 101(19):1348–1355
Chang Y, Cesarman E, Pessin MS et al (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266(5192):1865–1869
Chaturvedi AK (2012) Epidemiology and clinical aspects of HPV in head and neck cancers. Head Neck Pathol 6(Suppl 1):S16–S24
Chaturvedi AK, Engels EA, Pfeiffer RM et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294–4301
Choo QL, Kuo G, Weiner AJ et al (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244(4902):359–362
Clifford GM, Franceschi S (2009) Cancer risk in HIV-infected persons: influence of CD4(+) count. Future Oncol 5(5):669–678
Dane DS, Cameron CH, Briggs M et al (1970) Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet 1(7649):695–698
de Martel C, Ferlay J, Franceschi S et al (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13(6):607–615
Dürst M, Gissmann L, Ikenberg H et al (1983) A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 80:3812–3815
El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142(6):1264–1273 e1261
Epstein MA, Achong BG, Barr YM et al (1964) Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1(7335):702–703
Fan H, Johnson C (2011) Insertional oncogenesis by non-acute retroviruses: implications for gene therapy. Viruses 3(4):398–422
Feinstone SM, Hu DJ, Major ME (2012) Prospects for prophylactic and therapeutic vaccines against hepatitis C virus. Clin Infect Dis 55(Suppl 1):S25–S32
Feng H, Shuda M, Chang Y et al (2008) Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319(5866):1096–1100
Gallo RC (2011) Research and discovery of the first human cancer virus, HTLV-1. Best Pract Res Clin Haematol 24(4):559–565
Gantt S, Casper C (2011) Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment. Curr Opin Infect Dis 24(4):295–301
Gillison ML (2008) Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. J Adolesc Health 43(4 Suppl):S52–S60
Hill A (1971) Statistical evidence and inference. Principles of medical statistics, 9th edn. Oxford University Press, New York, pp 309–323
Howley PM, Livingston DM (2009) Small DNA tumor viruses: large contributors to biomedical sciences. Virology 384(2):256–259
Kutok JL, Wang F (2006) Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol 1:375–404
Lizardi PM, Forloni M, Wajapeyee N (2011) Genome-wide approaches for cancer gene discovery. Trends Biotechnol 29(11):558–568
Magrath I (2012) Epidemiology: clues to the pathogenesis of Burkitt lymphoma. Br J Haematol 156(6):744–756
Mesri E, Cesarman E, Boshoff C (2010) Kaposi’s sarcoma and its associated herpesvirus. Nat Rev Cancer 10(10):707–719
Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118(12):3030–3044
Poiesz BJ, Ruscetti FW, Mier JW et al (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 77(12):7415–7419
Poordad F, Dieterich D (2012) Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents. J Viral Hepat 19(7):449–464
Raab-Traub N (2012) Novel mechanisms of EBV-induced oncogenesis. Curr Opin Virol 2(4):453–458
Rama I, Grinyo JM (2010) Malignancy after renal transplantation: the role of immunosuppression. Nat Rev Nephrol 6(9):511–519
Romano G, Marino IR, Pentimalli F et al (2009) Insertional mutagenesis and development of malignancies induced by integrating gene delivery systems: implications for the design of safer gene-based interventions in patients. Drug News Perspect 22(4):185–196
Ruff AJ (1994) Breastmilk, breastfeeding, and transmission of viruses to the neonate. Semin Perinatol 18(6):510–516
Saha A, Robertson ES (2011) Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes. Clin Cancer Res 17(10):3056–3063
Saslow D, Solomon D, Lawson HW et al (2012) American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 62(3):147–172
Schiffman M, Wentzensen N, Wacholder S et al (2011) Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 103(5):368–383
Schiller JT, Buck CB (2011) Cutaneous squamous cell carcinoma: a smoking gun but still no suspects. J Invest Dermatol 131(8):1595–1596
Schiller JT, Lowy DR (2010) Vaccines to prevent infections by oncoviruses. Annu Rev Microbiol 64:23–41
Schiller JT, Lowy DR (2012) Understanding and learning from the success of prophylactic human papillomavirus vaccines. Nat Rev Microbiol 10(10):681–692
Shiels MS, Pfeiffer RM, Gail MH et al (2011) Cancer burden in the HIV-infected population in the United States.”. J Natl Cancer Inst 103(9):753–762
Smith BD, Jorgensen C, Zibbell JE et al (2012) Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update. Clin Infect Dis 55(Suppl 1):S49–S53
Sutcliffe S (2010) Sexually transmitted infections and risk of prostate cancer: review of historical and emerging hypotheses. Future Oncol 6(8):1289–1311
Uldrick TS, Whitby D (2011) Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma. Cancer Lett 305(2):150–162
Vinokurova S, Wentzensen N, Kraus I et al (2008) Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res 68(1):307–313
Wu TT, Blackman MA, Sun R (2010) Prospects of a novel vaccination strategy for human gamma-herpesviruses. Immunol Res 48(1–3):122–146
zur Hausen H (2009) Childhood leukemia’s and other hematopoietic malignancies: interdependence between an infectious event and chromosomal modifications. Int J Cancer 125(8):1764–1770
zur Hausen H (2012) Red meat consumption and cancer: reasons to suspect involvement of bovine infectious factors in colorectal cancer. Int J Cancer 130(11):2475–2483
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schiller, J.T., Lowy, D.R. (2014). Virus Infection and Human Cancer: An Overview. In: Chang, M., Jeang, KT. (eds) Viruses and Human Cancer. Recent Results in Cancer Research, vol 193. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38965-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-38965-8_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-38964-1
Online ISBN: 978-3-642-38965-8
eBook Packages: MedicineMedicine (R0)